References
- 1. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35(39):2733-79.
- 2. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults Maron BJ, Gardin JM, Flack JM, et al.. Circulation. Aug 15 1995;92(4):785-9.
- 3. Hypertrophic cardiomyopathy: current understanding and treatment objectives. Soor GS, Luk A, Ahn E, Abraham JR, Woo A, Ralph-Edwards A, et al. J Clin Pathol. Mar 2009;62(3):226-35.
- 4. Maron BJ. Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation 2007;116:196–206.
- 5. Leonardi RA, Kransdorf EP, Simel DL, Wang A. Metaanalyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment. Circ Cardiovasc Interv 2010;3:97–104.
- 6. Merrill WH, Friesinger GC, Graham TP Jr, Byrd BF 3rd, Drinkwater DC Jr, Christian KG, Bender HW Jr. Longlasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg 2000;69: 1732–1735.
- 7. McIntosh CL, Maron BJ, Cannon RO, Klues HG. Initial results of combined anterior mitral leaflet plication and ventricular septal myotomy-myectomy for relief of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy. Circulation 1992;86:II60–II67.
- 8. Matsui Y, Shiiya N, Murashita T, Sasaki S, Yasuda K. Mitral valve repair and septal myectomy for hypertrophic obstructive cardiomyopathy. J Cardiovasc Surg 2000; 41:53–56.
- 9. Kofflard MJ, van Herwerden LA,Waldstein DJ, Ruygrok P, Boersma E, Taams MA, ten Cate FJ. Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 1996;28:197–202.10.1016/0735-1097(96)00103-9
- 10. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003 Nov 5;42(9):1687-713.
- 11. Echocardiography in the treatment of hypertrophic cardiomyopathy Musat D, Sherrid MV. Anadolu Kardiyol Derg. Dec 2006;6 Suppl 2:18-26.
- 12. Woo A, Williams WG, Choi R, Wigle ED, Rozenblyum E, Fedwick K, Siu S,Ralph-Edwards A, Rakowski H. Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy. Circulation 2005;111:2033–2041.
- 13. Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, Gersh BJ, Ackerman MJ, McCully RB, Dearani JA, Schaff HV, Danielson GK, Tajik AJ, Nishimura RA. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005; 46:470–476.10.1016/j.jacc.2005.02.090
- 14. Dearani JA, Ommen SR, Gersh BJ, Schaff HV, Danielson GK. Surgery insight: septal myectomy for obstructive hypertrophic cardiomyopathy—the Mayo Clinic experience. Nat Clin Pract Cardiovasc Med 2007;4:503–512.10.1038/ncpcardio0965
- 15. Leonardi RA, Kransdorf EP, Simel DL, Wang A. Metaanalyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment. Circ Cardiovasc Interv 2010;3:97–104.
- 16. 2011 ACCF/AHA Guidelines for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Gersh BJ, Maron BJ, Bonow RO, et al. J Thorac Cardiovasc Surg. 2011 Dec;142(6):e153-203.
- 17. Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies. Afonso LC, Bernal J, Bax JJ, Abraham TP. JACC Cardiovasc Imaging. 2008 Nov;1(6):787-800.